Small cell lung cancer: staging with MR imaging.

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Small cell lung cancer (SCLC) is highly aggressive with frequent metastases at diagnosis.
• Conventional staging methods (bone marrow biopsy, bone scintigraphy, CT scans) have limitations in detecting the full extent of disease.

Purpose of the Study:

• To prospectively evaluate the efficacy of a comprehensive magnetic resonance (MR) imaging protocol for staging small cell lung cancer.
• To compare the diagnostic accuracy of MR imaging with conventional staging techniques.

Main Methods:

• A prospective study involving 25 patients with small cell lung cancer.
• Patients underwent both conventional staging and a standardized 1.5-T MR imaging protocol (pelvis, abdomen, spine, brain).
• Comparison of disease extent (limited vs. extensive) and detection of metastatic sites between the two staging methods.

Main Results:

• MR imaging identified more patients with extensive disease (19) compared to conventional staging (14).
• All metastatic sites detected by conventional staging were visualized on MR images.
• MR imaging revealed additional metastatic involvement in bone (4 patients) and liver (3 patients) not found with conventional staging.
• MR imaging correctly identified a hepatic hemangioma, distinguishing it from a potential metastasis seen on CT.

Conclusions:

• A single, comprehensive MR imaging study may accurately stage small cell lung cancer.
• MR imaging demonstrates superior sensitivity for detecting metastases in SCLC compared to conventional staging.
• These findings suggest MR imaging could be a valuable tool for optimizing SCLC patient management.